Protara Therapeutics Ownership | Who Owns Protara Therapeutics?

Protara Therapeutics Ownership Summary

Protara Therapeutics is owned by 46.79% institutional investors, 6.13% insiders, and 47.09% retail investors. Opaleye management is the largest institutional shareholder, holding 20.18% of TARA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.99% of its assets in Protara Therapeutics shares.

TARA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Protara Therapeutics	46.79%	6.13%	47.09%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Opaleye management	2.30M	20.18%	$5.30M
Ra capital management	1.90M	16.64%	$3.95M
Boxer capital	811.63K	7.11%	$1.69M
Baker bros. advisors lp	536.83K	4.70%	$1.12M
Velan capital investment management lp	480.00K	4.20%	$998.40K
Vanguard group	427.61K	3.74%	$889.43K
Cvi	302.75K	2.65%	$629.71K
Ikarian capital	180.71K	1.58%	$375.88K
Two sigma investments, lp	155.77K	1.36%	$324.01K
Renaissance	150.40K	1.32%	$312.83K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Opaleye management	2.30M	1.21%	$5.30M
Velan capital investment management lp	480.00K	0.57%	$998.40K
Cvi	302.75K	0.54%	$629.71K
Boxer capital	811.63K	0.09%	$1.69M
Ikarian capital	180.71K	0.07%	$375.88K
Ra capital management	1.90M	0.05%	$3.95M
Baker bros. advisors lp	536.83K	0.01%	$1.12M
Oppenheimer	127.18K	0.00%	$264.54K
Woodline partners lp	100.00K	0.00%	$208.00K
Bridgeway capital management	24.20K	0.00%	$50.34K

Top Buyers

Holder	Shares	% Assets	Change
Ra capital management	1.90M	0.05%	1.90M
Boxer capital	811.63K	0.09%	602.40K
Velan capital investment management lp	480.00K	0.57%	480.00K
Baker bros. advisors lp	536.83K	0.01%	337.16K
Cvi	302.75K	0.54%	302.75K

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-520.00K
Opaleye management	2.30M	1.21%	-388.33K
Privium fund management (uk)	-	-	-114.71K
Stempoint capital lp	-	-	-87.90K
Bridgeway capital management	24.20K	0.00%	-34.80K

New Positions

Holder	Shares	% Assets	Change	Value
Ra capital management	1.90M	0.05%	1.90M	$3.95M
Velan capital investment management lp	480.00K	0.57%	480.00K	$998.40K
Cvi	302.75K	0.54%	302.75K	$629.71K
Woodline partners lp	100.00K	0.00%	100.00K	$208.00K
Marshall wace, llp	77.35K	0.00%	77.35K	$160.89K

Sold Out

Holder	Change
Qube research	-2.00
Jpmorgan chase	-22.00
Adar1 capital management	-2.00K
Ubs group	-3.73K
Acadian asset management	-6.31K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	36	-14.29%	10,447,278	-0.02%	46	0.56%	18	-28.00%	7	-12.50%
Jun 30, 2024	42	7.69%	10,449,817	128.63%	91	5.62%	25	56.25%	8	-11.11%
Mar 31, 2024	39	21.88%	4,570,660	4.88%	40	2.73%	16	77.78%	9	50.00%
Dec 31, 2023	32	-	4,358,148	-14.85%	38	1.87%	9	28.57%	6	-33.33%
Sep 30, 2023	32	6.67%	5,117,943	-2.63%	45	2.09%	7	-12.50%	9	28.57%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	616.30K	2.99%	-
Vifag 2002 SICAV	150.00K	0.73%	-
Vanguard Institutional Extnd Mkt Idx Tr	140.67K	0.68%	-
A4Investments SICAV SIF ACCI IlanaA2EURH	125.00K	0.61%	-
Fidelity Extended Market Index	99.53K	0.48%	-7.54K
BlackRock Extended Equity Market K	54.38K	0.26%	-23.00
Bridgeway Ultra-Small Company Market	49.20K	0.24%	25.00K
iShares Micro-Cap ETF	41.24K	0.20%	-
Fidelity Total Market Index	30.44K	0.15%	18.73K
Fidelity Series Total Market Index	22.24K	0.11%	9.10K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 11, 2024	Opaleye Management Inc.	-	Sell	$53.14K
Sep 11, 2024	Opaleye Management Inc.	-	Sell	$2.74K
Sep 12, 2024	Opaleye Management Inc.	-	Sell	$11.11K
Sep 12, 2024	Opaleye Management Inc.	-	Sell	$204.73K
Sep 09, 2024	Opaleye Management Inc.	-	Sell	$65.54K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	18
2024 Q2	-	18
2024 Q1	-	-
2023 Q3	-	-
2023 Q2	-	-

TARA Ownership FAQ

Who Owns Protara Therapeutics?

Protara Therapeutics shareholders are primarily institutional investors at 46.79%, followed by 6.13% insiders and 47.08% retail investors. The average institutional ownership in Protara Therapeutics's industry, Biotech Stocks , is 47.04%, which Protara Therapeutics falls below.

Who owns the most shares of Protara Therapeutics?

Protara Therapeutics’s largest shareholders are Opaleye management (2.3M shares, 20.18%), Ra capital management (1.9M shares, 16.64%), and Boxer capital (811.63K shares, 7.11%). Together, they hold 43.92% of Protara Therapeutics’s total shares outstanding.

Does Blackrock own Protara Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Protara Therapeutics.

Who is Protara Therapeutics’s biggest shareholder by percentage of total assets invested?

Opaleye management is Protara Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.21% of its assets in 2.3M Protara Therapeutics shares, valued at 5.3M$.

Who is the top mutual fund holder of Protara Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Protara Therapeutics shares, with 2.99% of its total shares outstanding invested in 616.3K Protara Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools